-
Start Preamble
ACTION:
Notice of cancellation of consideration of a proposed action Start Printed Page 31796under Section III-A-1 of the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines).
SUMMARY:
Notice of a discussion of a proposed action under Section III-A-1 published on May 24, 2010 (75 FR 28811) is withdrawn. The discussion that was to be held at the June 16-17, 2010 meeting of the NIH Recombinant DNA Advisory Committee has been deferred at the request of the principal investigator.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
OBA by e-mail at oba@od.nih.gov, or telephone at 301-496-9838, if you have questions, or require additional information.
Start SignatureDated: May 26, 2010.
Jacqueline Corrigan-Curay,
Acting Director, Office of Biotechnology Activities, National Institutes of Health.
[FR Doc. 2010-13484 Filed 6-3-10; 8:45 am]
BILLING CODE 4140-01-P
Document Information
- Comments Received:
- 0 Comments
- Published:
- 06/04/2010
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Action:
- Notice of cancellation of consideration of a proposed action under Section III-A-1 of the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines).
- Document Number:
- 2010-13484
- Pages:
- 31795-31796 (2 pages)
- PDF File:
- 2010-13484.pdf
- Supporting Documents:
- » License Agreements; Start-Up Exclusive Evaluation Option: Activators of Human Pyruvate Kinase to Treat Cancer
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: National Institute of Nursing Research
- » Meetings: National Institute of Allergy and Infectious Diseases
- » Meetings: National Eye Institute
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: Center for Scientific Review
- » Meetings: Center for Scientific Review
- » Meetings: National Institute of Environmental Health Sciences
- » Meetings: National Human Genome Research Institute